Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,000,555 papers from all fields of science
Search
Sign In
Create Free Account
Vigabatrin 500 MG Oral Tablet [Sabril]
Known as:
Sabril 500 MG Oral Tablet
, VIGABATRIN 500 mg ORAL TABLET, FILM COATED [SABRIL]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
10 relations
Magnesium stearate
Oral Tablet
Polyethylene Glycols
Povidone
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Medication Utilization Patterns 90 Days Before Initiation of Treatment with Repository Corticotropin Injection in Patients with Infantile Spasms
L. Gold
,
T. Nazareth
,
+5 authors
R. Hansen
Pediatric Health, Medicine and Therapeutics
2019
Corpus ID: 211473662
Introduction Infantile spasms (IS) is a rare and devastating form of early childhood epilepsy. Two drugs are approved in the…
Expand
2016
2016
Sabril® registry 5-year results: Characteristics of adult patients treated with vigabatrin
G. Krauss
,
E. Faught
,
+9 authors
J. Isojarvi
Epilepsy & Behavior
2016
Corpus ID: 39761094
2016
2016
Which children receive vigabatrin? Characteristics of pediatric patients enrolled in the mandatory FDA registry
J. Pellock
,
E. Faught
,
+8 authors
J. Isojarvi
Epilepsy & Behavior
2016
Corpus ID: 3861698
2012
2012
PND44 Cost-Utility Analysis and Cost-Minimisation Analysis of Sabril® (Vigabatrin) in Drug-Resistant Epilepsy From Payer's Perspective in Poland
P. Kawalec
,
P. Holko
,
J. Lis
,
M. Glasek
2012
Corpus ID: 71503406
2011
2011
Screening for vigabatrin (Sabril®) retinal toxicity in children
S. Brodie
Ophthalmic Genetics
2011
Corpus ID: 10154118
Vigabatrin (Sabril®) is used as a drug of last resort in the treatment of refractory seizures. It is associated with a high risk…
Expand
Review
2004
Review
2004
A cost-utility analysis of adjunctive treatment with newer antiepileptic drugs in the UK
E. Remák
,
J. Hutton
,
C. Selai
,
M. Trimble
,
M. Price
2004
Corpus ID: 74513421
Summary A recent review found that economic assessment of epilepsy treatment relies largely on hypothetical modelling of outcomes…
Expand
2000
2000
Der derzeitige Stellenwert von Vigabatrin (Sabril®) in der Epilepsiebehandlung - Ergebnisse einer Konsenskonferenz*
D. Schmidt
,
U. Brandl
,
+13 authors
S. Stodieck
2000
Corpus ID: 72413061
1997
1997
Obstructive sleep apnoea following rapid weight gain secondary to treatment with vigabatrin (Sabril®)
M. Lambert
,
J. Bird
Seizure
1997
Corpus ID: 12497590
1997
1997
Multicentre clinical evaluation of vigabatrin (Sabril®) in mild to moderate partial epilepsies
A. Arzimanoglou
,
C. Dumas
,
L. Ghirardi
Seizure
1997
Corpus ID: 19030315
1997
1997
P-2-203 Analysis of the efficacy of vigabatrin (Sabril®) in traumatic epilepsy
H. Kasprzak
,
P. Osiński
,
M. Bierwagen
,
M. Śniegocki
,
W. Beuth
Clinical neurology and neurosurgery (Dutch…
1997
Corpus ID: 54279975
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE